Halaman 2 - Imunoterapi untuk kanker prostat Imunoterapi untuk kanker prostat Terbaik - TOP-40 dokter

Dr. Ozden memadukan pengalaman medis 16+ tahun dengan spesialisasi di bidang onkologi di Universitas Kocaeli.

• Menyelesaikan pelatihan subspesialisasi Onkologi Medis
• Pernah bekerja di beragam lingkungan rumah sakit, mulai dari rumah sakit negeri hingga rumah sakit universitas
• Menjalani pelatihan di Fakultas Cerrahpaşa yang bergengsi dari Universitas Istanbul

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Nail Paksoy berspesialisasi dalam onkologi medis, dengan fokus pada imunoterapi untuk kanker prostat di Rumah Sakit Medipol Bahçelievler.

• Bersertifikat Dewan (Board-certified) oleh ESMO dalam onkologi medis
• Berpartisipasi dalam berbagai uji klinis internasional untuk pengobatan kanker
• Menerbitkan banyak artikel penelitian tentang onkologi dan imunoterapi
• Associate Professor di Universitas Medipol Istanbul

Assoc. Prof. Atakan Topcu berspesialisasi dalam terapi target dan imunoterapi untuk kanker prostat di Rumah Sakit Distrik Medipol Acibadem.

• Telah menerbitkan lebih dari 50 artikel ilmiah di bidang onkologi
• Anggota Masyarakat Eropa untuk Onkologi Medis (ESMO)
• Mendapatkan pelatihan Fellowship dalam Onkologi Medis di Universitas Bezmialem Vakıf
• Keahlian dalam onkologi geriatri dan malnutrisi terkait kanker

Profesor Madya Onkologi Medis di Rumah Sakit Liv Universitas İstinye Topkapı, berspesialisasi dalam imunoterapi untuk kanker prostat.

• Anggota American Society of Clinical Oncology (ASCO) sejak 2018
• Telah menerbitkan berbagai artikel yang ditinjau sejawat tentang hasil pengobatan kanker
• Koordinator Pendidikan untuk Sub-Cabang Onkologi Medis di Rumah Sakit Kota Prof. Dr. Cemil Taşcıoğlu

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Spesialisasi dalam radioterapi – Dr. Sridhar P.S. membawa keahlian mendalam dalam pengobatan kanker prostat di HCG Manavata Cancer Centre.

• Diplomate of National Board dalam radioterapi
• Anggota Association of Radiation Oncology of India
• Bagian dari Bangalore Oncology Group
• Spesialis dalam neuro-onkologi dan onkologi hipertermia

Lebih dari 50.000 operasi kanker dilakukan selama 19 tahun – Dr. Nagarkar berspesialisasi dalam onkologi bedah dengan fokus pada peningkatan kualitas hidup pasien.

• Menempuh pendidikan di Tata Memorial Hospital dan Royal College of Surgeons, Edinburgh
• Melakukan lebih dari 200 uji klinis pada fase 1-3
• Spesialisasi dalam onkologi bedah payudara dan toraks
• Profesor untuk DNB Superspecialty Surgical Oncology dan Bedah Payudara

Mempresentasikan penelitian tentang kanker lambung di simposium American Society of Clinical Oncology – Dr. Valame berspesialisasi dalam terapi target untuk kanker prostat.

• DNB dalam Onkologi Medis dari Rumah Sakit Indraprastha Apollo
• Registrar dalam Onkologi Medis di Rumah Sakit Kanker Jawaharlal Nehru
• Dosen di International Winter School of Oncology
• Keahlian dalam dasar molekuler kanker

10.000+ operasi besar dilakukan selama 10 tahun, berspesialisasi dalam operasi kanker invasif minimal dengan hasil yang sangat baik.

• Pelatihan fellowship dalam onkologi bedah di Tata Medical Centre, Kolkata
• Fokus khusus pada operasi kanker gastrointestinal
• Co-principal investigator dalam berbagai proyek penelitian orisinal
• Dipublikasikan di jurnal nasional dan internasional

Dr. Ahmer Arif Shaikh berspesialisasi dalam onkologi bedah dengan fokus pada kanker mulut dan rehabilitasi fungsional di HCG Manavata Cancer Centre.

• 3 tahun pengalaman dalam onkologi bedah
• Keahlian dalam pelestarian organ dan rehabilitasi fungsional
• Mahir dalam operasi maksilofasial besar dan operasi kepala & leher
• Terlatih Fellowship dalam Onkologi Bedah Kepala & Leher
• Peneliti aktif dengan banyak publikasi

Dr. Shruti Kate berspesialisasi dalam imunoterapi untuk kanker stadium lanjut, termasuk kanker prostat, dengan pelatihan di Tata Memorial Hospital – pusat kanker terkemuka di India.

• DM dalam Onkologi Medis dari Tata Memorial Hospital
• Keahlian dalam kanker paru-paru, payudara, dan genitourinari
• Anggota ASCO, ESMO, dan perkumpulan onkologi terkemuka lainnya
• Mempresentasikan penelitian di Konferensi Dunia tentang Kanker Paru-paru

Dr. Borde telah melakukan lebih dari 30.000 pemindaian PET dan merawat 1.000+ pasien kanker tiroid di HCG Manavata Cancer Centre.

• 12 tahun pengalaman dalam kedokteran nuklir
• Spesialisasi dalam terapi radioiodin dan Lu-177 RN
• Penelitian yang dipublikasikan dalam jurnal medis
• Ahli dalam pemindaian PET-CT dan kardiologi nuklir